These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 11061579

  • 1. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL, Lasseter KC, Shamblen EC, Agarwal V, Lettieri J, Sundaresen P.
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [Abstract] [Full Text] [Related]

  • 2. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors.
    Jacobson TA.
    Am J Cardiol; 2004 Nov 01; 94(9):1140-6. PubMed ID: 15518608
    [Abstract] [Full Text] [Related]

  • 3. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1999 Aug 01; 66(2):118-27. PubMed ID: 10460065
    [Abstract] [Full Text] [Related]

  • 4. The interaction of diltiazem with lovastatin and pravastatin.
    Azie NE, Brater DC, Becker PA, Jones DR, Hall SD.
    Clin Pharmacol Ther; 1998 Oct 01; 64(4):369-77. PubMed ID: 9797793
    [Abstract] [Full Text] [Related]

  • 5. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
    Dong J, Yu X, Wang L, Sun YB, Chen XJ, Wang GJ.
    Acta Pharmacol Sin; 2008 Oct 01; 29(10):1247-52. PubMed ID: 18817631
    [Abstract] [Full Text] [Related]

  • 6. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
    Backman JT, Luurila H, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Aug 01; 78(2):154-67. PubMed ID: 16084850
    [Abstract] [Full Text] [Related]

  • 7. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ, Kantola T, Kivistö KT.
    Clin Pharmacol Ther; 1998 Mar 01; 63(3):332-41. PubMed ID: 9542477
    [Abstract] [Full Text] [Related]

  • 8. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT.
    Clin Ther; 2006 Jan 01; 28(1):45-54. PubMed ID: 16490579
    [Abstract] [Full Text] [Related]

  • 9. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
    Cilla DD, Whitfield LR, Gibson DM, Sedman AJ, Posvar EL.
    Clin Pharmacol Ther; 1996 Dec 01; 60(6):687-95. PubMed ID: 8988072
    [Abstract] [Full Text] [Related]

  • 10. Effect of itraconazole on the pharmacokinetics of atorvastatin.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 1998 Jul 01; 64(1):58-65. PubMed ID: 9695720
    [Abstract] [Full Text] [Related]

  • 11. Gemfibrozil greatly increases plasma concentrations of cerivastatin.
    Backman JT, Kyrklund C, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2002 Dec 01; 72(6):685-91. PubMed ID: 12496749
    [Abstract] [Full Text] [Related]

  • 12. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May 01; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
    Hulskotte EG, Feng HP, Xuan F, Gupta S, van Zutven MG, O'Mara E, Wagner JA, Butterton JR.
    Antimicrob Agents Chemother; 2013 Jun 01; 57(6):2582-8. PubMed ID: 23529734
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic interactions between nelfinavir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and simvastatin.
    Hsyu PH, Schultz-Smith MD, Lillibridge JH, Lewis RH, Kerr BM.
    Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3445-50. PubMed ID: 11709322
    [Abstract] [Full Text] [Related]

  • 15. No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran.
    Sarich TC, Schützer KM, Dorani H, Wall U, Kalies I, Ohlsson L, Eriksson UG.
    J Clin Pharmacol; 2004 Aug 01; 44(8):928-34. PubMed ID: 15286097
    [Abstract] [Full Text] [Related]

  • 16. Lack of drug-drug interaction between cerivastatin and nifedipine.
    Sachse R, Brendel E, Mück W, Rohde G, Ochmann K, Horstmann R, Kuhlmann J.
    Int J Clin Pharmacol Ther; 1998 Aug 01; 36(8):409-13. PubMed ID: 9726692
    [Abstract] [Full Text] [Related]

  • 17. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ, Jalava KM.
    Clin Pharmacol Ther; 1996 Jul 01; 60(1):54-61. PubMed ID: 8689812
    [Abstract] [Full Text] [Related]

  • 18. Effect of itraconazole on cerivastatin pharmacokinetics.
    Kantola T, Kivistö KT, Neuvonen PJ.
    Eur J Clin Pharmacol; 1999 Jan 01; 54(11):851-5. PubMed ID: 10027660
    [Abstract] [Full Text] [Related]

  • 19. Erythromycin coadministration increases plasma atorvastatin concentrations.
    Siedlik PH, Olson SC, Yang BB, Stern RH.
    J Clin Pharmacol; 1999 May 01; 39(5):501-4. PubMed ID: 10234598
    [Abstract] [Full Text] [Related]

  • 20. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W, Ritter W, Dietrich H, Frey R, Kuhlmann J.
    Int J Clin Pharmacol Ther; 1997 Jun 01; 35(6):261-4. PubMed ID: 9208343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.